180 related articles for article (PubMed ID: 32248632)
1. Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan.
Nakagawa S; Ueda Y; Yagi A; Ikeda S; Hiramatsu K; Kimura T
Cancer Sci; 2020 Jun; 111(6):2156-2162. PubMed ID: 32248632
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of catch-up and routine program of the 9-valent vaccine on cervical cancer risk reduction in Japan.
Yagi A; Nakagawa S; Ueda Y; Oka E; Ikeda S; Kakuda M; Kobayashi E; Ito Y; Katayama K; Hirai K; Nakayama T; Kimura T
Cancer Sci; 2024 Mar; 115(3):916-925. PubMed ID: 38158850
[TBL] [Abstract][Full Text] [Related]
3. The last strategy for re-dissemination of HPV vaccination in Japan while still under the suspension of the governmental recommendation.
Ueda Y; Yagi A; Abe H; Nakagawa S; Minekawa R; Kuroki H; Miwa A; Kimura T
Sci Rep; 2020 Sep; 10(1):16091. PubMed ID: 32999408
[TBL] [Abstract][Full Text] [Related]
4. HPV vaccination in Japan: what is happening in Japan?
Ikeda S; Ueda Y; Yagi A; Matsuzaki S; Kobayashi E; Kimura T; Miyagi E; Sekine M; Enomoto T; Kudoh K
Expert Rev Vaccines; 2019 Apr; 18(4):323-325. PubMed ID: 30768373
[No Abstract] [Full Text] [Related]
5. Realistic fear of cervical cancer risk in Japan depending on birth year.
Yagi A; Ueda Y; Egawa-Takata T; Tanaka Y; Nakae R; Morimoto A; Terai Y; Ohmichi M; Ichimura T; Sumi T; Murata H; Okada H; Nakai H; Mandai M; Matsuzaki S; Kobayashi E; Yoshino K; Kimura T; Saito J; Hori Y; Morii E; Nakayama T; Suzuki Y; Motoki Y; Sukegawa A; Asai-Sato M; Miyagi E; Yamaguchi M; Kudo R; Adachi S; Sekine M; Enomoto T; Horikoshi Y; Takagi T; Shimura K
Hum Vaccin Immunother; 2017 Jul; 13(7):1700-1704. PubMed ID: 28272968
[TBL] [Abstract][Full Text] [Related]
6. Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation.
Larson HJ; Wilson R; Hanley S; Parys A; Paterson P
Hum Vaccin Immunother; 2014; 10(9):2543-50. PubMed ID: 25483472
[TBL] [Abstract][Full Text] [Related]
7. Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination.
Morimoto A; Ueda Y; Egawa-Takata T; Yagi A; Terai Y; Ohmichi M; Ichimura T; Sumi T; Murata H; Kanzaki H; Nakai H; Mandai M; Yoshino K; Fujita M; Kimura T; Saito J; Sobue T; Nishikawa N; Sekine M; Enomoto T; Horikoshi Y; Takagi T
Int J Clin Oncol; 2015 Jun; 20(3):549-55. PubMed ID: 25001869
[TBL] [Abstract][Full Text] [Related]
8. Contemplating HPV vaccination in Japan during the time of COVID-19.
Miyoshi A; Ueda Y; Kimura T
Hum Vaccin Immunother; 2021 Mar; 17(3):836-837. PubMed ID: 32961077
[TBL] [Abstract][Full Text] [Related]
9. A questionnaire survey on the prevention of HPV infection among females and males who came of age in Japan under various scenarios of HPV vaccine recommendation.
Ishimoto T; Yagi A; Nakajima K; Okamoto N; Yukimitsu E; Kawasaki M; Kawae Y; Hayasaka S; Ueda Y; Kimura T
Hum Vaccin Immunother; 2023 Aug; 19(2):2229222. PubMed ID: 37462048
[TBL] [Abstract][Full Text] [Related]
10. The controversy on HPV vaccination in Japan: Criticism of the ethical validity of the arguments for the suspension of the proactive recommendation.
Okita T; Enzo A; Kadooka Y; Tanaka M; Asai A
Health Policy; 2020 Feb; 124(2):199-204. PubMed ID: 31924344
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus vaccination of the daughters of obstetricians and gynecologists in Japan.
Egawa-Takata T; Ueda Y; Morimoto A; Tanaka Y; Matsuzaki S; Kobayashi E; Yoshino K; Sekine M; Enomoto T; Kimura T
Int J Clin Oncol; 2016 Feb; 21(1):53-8. PubMed ID: 26155971
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of future cervical cancer risk in Japan, based on birth year.
Yagi A; Ueda Y; Ikeda S; Sekine M; Nakayama T; Miyagi E; Enomoto T
Vaccine; 2019 May; 37(22):2889-2891. PubMed ID: 31027925
[TBL] [Abstract][Full Text] [Related]
13. A nationwide birth year-by-year analysis of effectiveness of HPV vaccine in Japan.
Yagi A; Ueda Y; Nakagawa S; Masuda T; Miyatake T; Ikeda S; Abe H; Hirai K; Sekine M; Miyagi E; Enomoto T; Nakayama T; Kimura T
Cancer Sci; 2021 Sep; 112(9):3691-3698. PubMed ID: 34252250
[TBL] [Abstract][Full Text] [Related]
14. Time-dependent changes of the intention of mothers in Japan to inoculate their daughters with the HPV vaccine after suspension of governmental recommendation.
Yagi A; Ueda Y; Tanaka Y; Nakae R; Kakubari R; Morimoto A; Terai Y; Ohmichi M; Ichimura T; Sumi T; Murata H; Okada H; Nakai H; Matsumura N; Yoshino K; Kimura T; Saito J; Ikeda S; Asai-Sato M; Miyagi E; Sekine M; Enomoto T; Hirai K; Horikoshi Y; Takagi T; Shimura K
Hum Vaccin Immunother; 2018; 14(10):2497-2502. PubMed ID: 29883254
[TBL] [Abstract][Full Text] [Related]
15. Changing trends in HPV vaccination in Japan.
Ujiie M; Kitano T; Tsuzuki S
Hum Vaccin Immunother; 2022 Dec; 18(1):1-3. PubMed ID: 34619059
[TBL] [Abstract][Full Text] [Related]
16. Compensation programs after withdrawal of the recommendation for HPV vaccine in Japan.
Yuji K; Nakada H
Hum Vaccin Immunother; 2016 May; 12(5):1321-4. PubMed ID: 26513303
[TBL] [Abstract][Full Text] [Related]
17. Potential for cervical cancer incidence and death resulting from Japan's current policy of prolonged suspension of its governmental recommendation of the HPV vaccine.
Yagi A; Ueda Y; Nakagawa S; Ikeda S; Tanaka Y; Sekine M; Miyagi E; Enomoto T; Kimura T
Sci Rep; 2020 Sep; 10(1):15945. PubMed ID: 32994516
[TBL] [Abstract][Full Text] [Related]
18. Can Catch-Up Vaccinations Fill the Void Left by Suspension of the Governmental Recommendation of HPV Vaccine in Japan?
Yagi A; Ueda Y; Nakagawa S; Ikeda S; Kakuda M; Hiramatsu K; Miyoshi A; Kobayashi E; Kimura T; Mizushima T; Suzuki Y; Sekine M; Hirai K; Nakayama T; Miyagi E; Enomoto T; Kimura T
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146533
[TBL] [Abstract][Full Text] [Related]
19. HPV vaccination in Japan: results of a 3-year follow-up survey of obstetricians and gynecologists regarding their opinions toward the vaccine.
Sawada M; Ueda Y; Yagi A; Morimoto A; Nakae R; Kakubari R; Abe H; Egawa-Takata T; Iwamiya T; Matsuzaki S; Kobayashi E; Yoshino K; Kimura T
Int J Clin Oncol; 2018 Feb; 23(1):121-125. PubMed ID: 28986659
[TBL] [Abstract][Full Text] [Related]
20. Dynamic changes in Japan's prevalence of abnormal findings in cervical cervical cytology depending on birth year.
Ueda Y; Yagi A; Nakayama T; Hirai K; Ikeda S; Sekine M; Miyagi E; Enomoto T
Sci Rep; 2018 Apr; 8(1):5612. PubMed ID: 29618795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
